$CATX
Perspective Therapeutics, Inc.

2018 Form 10-K Financial Statement

#000143774918017492 Filed on September 26, 2018

View on sec.gov

Income Statement

Concept 2018 2017 Q2 2017 Q1
Revenue $5.923M $1.370M $1.282M
YoY Change 24.41% 22.32% 7.01%
Cost Of Revenue $4.081M $870.0K $989.0K
YoY Change 4.03% -25.64% -12.63%
Gross Profit $1.842M $498.0K $293.0K
YoY Change 119.81% -1137.5% 343.94%
Gross Profit Margin 31.1% 36.35% 22.85%
Selling, General & Admin $6.825M $2.050M $1.355M
YoY Change 9.55% 34.87% 11.89%
% of Gross Profit 370.52% 411.65% 462.46%
Research & Development $1.746M $320.0K $327.0K
YoY Change 80.93% 128.57% 78.69%
% of Gross Profit 94.79% 64.26% 111.6%
Depreciation & Amortization $80.00K $30.00K $40.00K
YoY Change 17.65% -78.57% -71.43%
% of Gross Profit 4.34% 6.02% 13.65%
Operating Expenses $8.571M $2.360M $1.682M
YoY Change 19.96% 96.67% 20.66%
Operating Profit -$6.729M -$1.862M -$1.389M
YoY Change 6.69% 49.2% 4.67%
Interest Expense $30.00K $30.00K
YoY Change -57.14%
% of Operating Profit
Other Income/Expense, Net $29.00K -$20.00K $29.00K
YoY Change -80.0% -95.65% -78.03%
Pretax Income -$6.700M -$1.860M -$1.360M
YoY Change 8.73% 57.63% 13.33%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.700M -$1.854M -$1.360M
YoY Change 8.73% 56.46% 13.81%
Net Earnings / Revenue -113.12% -135.33% -106.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$121.5K -$33.81K -$24.72K
COMMON SHARES
Basic Shares Outstanding 55.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 2017 Q2 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.425M $8.970M $10.41M
YoY Change -61.82% -27.6% -10.34%
Cash & Equivalents $2.600M $5.932M $5.100M
Short-Term Investments $825.0K $3.040M $5.310M
Other Short-Term Assets $294.0K $30.00K $350.0K
YoY Change 44.12% 11.11% 20.69%
Inventory $494.0K $323.0K $310.0K
Prepaid Expenses
Receivables $1.192M $730.0K $850.0K
Other Receivables $41.00K $67.00K $0.00
Total Short-Term Assets $5.446M $10.29M $11.92M
YoY Change -47.08% -24.49% -9.95%
LONG-TERM ASSETS
Property, Plant & Equipment $1.311M $1.054M $1.013M
YoY Change 24.38% 82.67% 143.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $500.0K $230.0K $267.0K
YoY Change -27.95% 52.32% 19.98%
Total Long-Term Assets $2.009M $1.978M $2.018M
YoY Change 1.57% -55.78% -69.22%
TOTAL ASSETS
Total Short-Term Assets $5.446M $10.29M $11.92M
Total Long-Term Assets $2.009M $1.978M $2.018M
Total Assets $7.455M $12.27M $13.94M
YoY Change -39.24% -32.22% -29.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.391M $630.0K $710.0K
YoY Change 120.79% 3.28% -2.74%
Accrued Expenses $444.0K $480.0K $430.0K
YoY Change -6.72% 0.0% -10.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.835M $1.106M $1.140M
YoY Change 65.91% 1.1% -5.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $590.0K $560.0K $550.0K
YoY Change 5.17% -8.2% -48.11%
Total Long-Term Liabilities $590.0K $560.0K $550.0K
YoY Change 5.17% -8.2% -48.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.835M $1.106M $1.140M
Total Long-Term Liabilities $590.0K $560.0K $550.0K
Total Liabilities $2.425M $1.667M $1.694M
YoY Change 45.47% -2.0% -25.41%
SHAREHOLDERS EQUITY
Retained Earnings -$72.60M -$70.75M
YoY Change 9.27% 8.42%
Common Stock $83.21M $83.00M
YoY Change 0.44% 0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.030M $10.60M $12.25M
YoY Change
Total Liabilities & Shareholders Equity $7.455M $12.27M $13.94M
YoY Change -39.24% -32.22% -29.58%

Cashflow Statement

Concept 2018 2017 Q2 2017 Q1
OPERATING ACTIVITIES
Net Income -$6.700M -$1.854M -$1.360M
YoY Change 8.73% 56.46% 13.81%
Depreciation, Depletion And Amortization $80.00K $30.00K $40.00K
YoY Change 17.65% -78.57% -71.43%
Cash From Operating Activities -$5.712M -$1.210M -$1.490M
YoY Change 0.0% 0.83% 96.05%
INVESTING ACTIVITIES
Capital Expenditures $337.0K -$230.0K -$50.00K
YoY Change -38.62% 0.0% -76.19%
Acquisitions
YoY Change
Other Investing Activities $2.214M $2.280M -$30.00K
YoY Change 1.23% -61.22% -100.5%
Cash From Investing Activities $1.859M $2.040M -$80.00K
YoY Change 22.79% -63.96% -101.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $479.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 521.0K 0.000 0.000
YoY Change -5888.89%
NET CHANGE
Cash From Operating Activities -5.712M -1.210M -1.490M
Cash From Investing Activities 1.859M 2.040M -80.00K
Cash From Financing Activities 521.0K 0.000 0.000
Net Change In Cash -3.332M 830.0K -1.570M
YoY Change -20.8% -81.39% -131.4%
FREE CASH FLOW
Cash From Operating Activities -$5.712M -$1.210M -$1.490M
Capital Expenditures $337.0K -$230.0K -$50.00K
Free Cash Flow -$6.049M -$980.0K -$1.440M
YoY Change -3.39% 1.03% 161.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
CY2018 dei Document Type
DocumentType
10-K
CY2017Q4 dei Entity Public Float
EntityPublicFloat
22040092
CY2018 isr Adjustments To Additional Paid In Capital Sharebased Compensation Third Party Services
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationThirdPartyServices
203000
CY2018 isr Adoption Of Asu201609 Reclassification From Retained Earnings To Additional Paid In Capital
AdoptionOfASU201609ReclassificationFromRetainedEarningsToAdditionalPaidInCapital
CY2016 isr Asset Retirement Obligation Assumed Credit Adjusted Risk Free Rate
AssetRetirementObligationAssumedCreditAdjustedRiskFreeRate
0.051
CY2016 isr Asset Retirement Obligation Assumed Inflation Factor
AssetRetirementObligationAssumedInflationFactor
0.011
CY2018 isr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
0.01
CY2016 isr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
1.63
CY2017 isr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
0.94
CY2018 isr Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
0.28
CY2018 isr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
250000
CY2016 isr Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
155713
CY2017 isr Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
230087
CY2018 isr Class Of Warrant Or Right Issued For Services
ClassOfWarrantOrRightIssuedForServices
500000
CY2018 isr Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1
CY2017 isr Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1
CY2016Q2 isr Estimated Asset Retirement Cost
EstimatedAssetRetirementCost
650000
CY2018 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
CY2017 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
48000
CY2016 isr Gain Loss On Change In Aro Estimate
GainLossOnChangeInAROEstimate
456000
CY2018 isr Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
CY2017 isr Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-9000
CY2016 isr Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-54000
CY2018 isr Increase Decrease In Estimate On Patents And Trademarks
IncreaseDecreaseInEstimateOnPatentsAndTrademarks
CY2017 isr Increase Decrease In Estimate On Patents And Trademarks
IncreaseDecreaseInEstimateOnPatentsAndTrademarks
CY2016 isr Increase Decrease In Estimate On Patents And Trademarks
IncreaseDecreaseInEstimateOnPatentsAndTrademarks
73000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4912000
CY2015Q4 isr Purchase Obligation Agreement Period
PurchaseObligationAgreementPeriod
P1Y
CY2018 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
395000
CY2017 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
194000
CY2016 isr Research And Development Collaboration Services Net Of Reimbursement
ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
CY2018 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
1351000
CY2017 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
771000
CY2016 isr Research And Development Proprietary Research And Development
ResearchAndDevelopmentProprietaryResearchAndDevelopment
528000
CY2017 isr Share Based Compensation Arrangement By Share Based Payment Award Options Voided
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVoided
1179164
CY2017 isr Sharebased Compensation Arrangements By Sharebased Payment Award Options Voided In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsVoidedInPeriodWeightedAverageExercisePrice
0.94
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1391000
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
630000
CY2018Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
77000
CY2017Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
75000
CY2018Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
175000
CY2017Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
138000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7671000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7591000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
84322000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83151000
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
50000
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
45000
CY2016 us-gaap Adjustment For Amortization
AdjustmentForAmortization
107000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
291000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
372000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
404000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
404000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
372000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
290000
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
45000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4068905
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3438256
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3214211
CY2015Q3 us-gaap Area Of Land
AreaOfLand
4.2
CY2016Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
580000
CY2017Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
561000
CY2018Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
590000
CY2018 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
29000
CY2017 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
29000
CY2016 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
89000
CY2016 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-456000
CY2017 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-48000
CY2018 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
CY2018Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
590000
CY2017Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
561000
CY2018Q2 us-gaap Assets
Assets
7455000
CY2017Q2 us-gaap Assets
Assets
12269000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
5446000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
10291000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2600000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5932000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10139000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5227000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3332000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4207000
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.22
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.94
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.54
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
250000
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
385800
CY2016Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
230087
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56331147
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55017419
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56331147
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55017419
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
56000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
55000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4081000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3923000
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4640000
CY2018Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15020000
CY2017Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22723000
CY2018Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14171000
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21302000
CY2018Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
10000
CY2017Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
9000
CY2018Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
197000
CY2017Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
519000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
480000
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
664000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
124000
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
196000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
38000
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
33000
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15020000
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22723000
CY2018 us-gaap Depreciation
Depreciation
80000
CY2017 us-gaap Depreciation
Depreciation
68000
CY2016 us-gaap Depreciation
Depreciation
471000
CY2016 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
11000
CY2017 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
11000
CY2018 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
11000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.28
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
155000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
138000
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
691000
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y76D
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
778000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
778000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
55000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
50000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
23000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
23000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
23000
CY2017Q3 us-gaap Gross Profit
GrossProfit
265000
CY2017Q4 us-gaap Gross Profit
GrossProfit
531000
CY2018Q1 us-gaap Gross Profit
GrossProfit
609000
CY2018Q2 us-gaap Gross Profit
GrossProfit
437000
CY2016Q3 us-gaap Gross Profit
GrossProfit
48000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4165000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3918000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3786000
CY2018 us-gaap Gross Profit
GrossProfit
1842000
CY2017 us-gaap Gross Profit
GrossProfit
838000
CY2016 us-gaap Gross Profit
GrossProfit
129000
CY2016Q4 us-gaap Gross Profit
GrossProfit
-1000
CY2017Q1 us-gaap Gross Profit
GrossProfit
293000
CY2017Q2 us-gaap Gross Profit
GrossProfit
498000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
9500000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24000
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
976000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1008000
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
198000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
230000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-7703000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2123000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1675000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
9556000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1878000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2157000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1649000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
21000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
17000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
7000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
4000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
16000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
21000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
10000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
761000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
112000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
466000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
184000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-444000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
17000
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
66000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-141000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-23000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-89000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23000
CY2018 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2000
CY2017 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-47000
CY2016 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2000
CY2018 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-88000
CY2017 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-52000
CY2016 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
48000
CY2018 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
37000
CY2017 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
27000
CY2016 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-16000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
64000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-100000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
21000
CY2018 us-gaap Interest Expense
InterestExpense
CY2017 us-gaap Interest Expense
InterestExpense
CY2016 us-gaap Interest Expense
InterestExpense
1000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
CY2017 us-gaap Interest Paid Net
InterestPaidNet
CY2016 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2018Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27000
CY2017Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11000
CY2018Q2 us-gaap Inventory Net
InventoryNet
494000
CY2017Q2 us-gaap Inventory Net
InventoryNet
323000
CY2018Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
319000
CY2017Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
513000
CY2018Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
371000
CY2017Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
191000
CY2018Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
96000
CY2017Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
121000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
72000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
118000
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
218000
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
203000
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2017Q2 us-gaap Land
Land
365900
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
285000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
288000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
292000
CY2018Q2 us-gaap Liabilities
Liabilities
2425000
CY2017Q2 us-gaap Liabilities
Liabilities
1667000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7455000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12269000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1835000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1106000
CY2018 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
329000
CY2017 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
323000
CY2016 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
157000
CY2018 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: top;"> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div></div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Organization</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">IsoRay, Inc. was incorporated in Minnesota in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1983.</div> On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 28, 2005, </div>IsoRay Medical, Inc. (Medical) became a wholly-owned subsidiary of IsoRay, Inc. (formerly known as Century Park Pictures Corporation) pursuant to a merger. Medical was formed under Delaware law on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 15, 2004 </div>and on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2004 </div>acquired <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> affiliated predecessor companies which began operations in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1998.</div> Medical, a Delaware corporation, develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Medical is headquartered in Richland, Washington.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">IsoRay International LLC (International), a Washington limited liability company, was formed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 27, 2007 </div>and is a wholly-owned subsidiary of IsoRay, Inc. International has entered into various international distribution agreements.</div></div>
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
521000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1859000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1514000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8757000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5712000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5712000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3884000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6700000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-6162000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-4711000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-1546000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1463000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1332000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2359000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1498000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-1450000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-1360000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
290000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
241000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1854000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6711000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6173000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4722000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
29000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
145000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
371000
CY2018 us-gaap Open Tax Year
OpenTaxYear
2016 2017 2018
CY2018 us-gaap Operating Expenses
OperatingExpenses
8571000
CY2017 us-gaap Operating Expenses
OperatingExpenses
7145000
CY2016 us-gaap Operating Expenses
OperatingExpenses
5211000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-6729000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-6307000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-5082000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
821000
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
290000
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
67000000
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
29000
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
30000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
198000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
125000
CY2018Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
241000
CY2017Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
122000
CY2018Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
41000
CY2017Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
67000
CY2018 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
CY2017 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
CY2016 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
11000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18000
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
124000
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
13000
CY2015Q3 us-gaap Payments To Acquire Land Held For Use
PaymentsToAcquireLandHeldForUse
168000
CY2017Q2 us-gaap Payments To Acquire Land Held For Use
PaymentsToAcquireLandHeldForUse
197900
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
337000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
549000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
479000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4054000
CY2017 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
115000
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6243000
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
11000
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
11000
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
11000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671
CY2018Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
9000
CY2017Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
11000
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
335000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
271000
CY2018Q2 us-gaap Prepaid Insurance
PrepaidInsurance
24000
CY2017Q2 us-gaap Prepaid Insurance
PrepaidInsurance
52000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
479000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2018 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
6268000
CY2017 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2296000
CY2016 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
15492000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3000
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8982000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8645000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1311000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1054000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-4000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2018Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1192000
CY2017Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
726000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
965000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
528000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1746000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79348000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72604000
CY2018 us-gaap Revenues
Revenues
5923000
CY2017 us-gaap Revenues
Revenues
4761000
CY2016 us-gaap Revenues
Revenues
4769000
CY2017Q3 us-gaap Revenues
Revenues
1211000
CY2017Q4 us-gaap Revenues
Revenues
1536000
CY2018Q1 us-gaap Revenues
Revenues
1573000
CY2018Q2 us-gaap Revenues
Revenues
1603000
CY2016Q3 us-gaap Revenues
Revenues
1081000
CY2016Q4 us-gaap Revenues
Revenues
1028000
CY2017Q1 us-gaap Revenues
Revenues
1282000
CY2017Q2 us-gaap Revenues
Revenues
1370000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
263000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
692000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2418282
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2660000
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2310000
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1353000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
404000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
372000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
290000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2068432
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.82
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
28000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
100000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
509904
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
459594
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
162869
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
561541
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1125000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2150000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1185500
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.34
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.45
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.60
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
151000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3759840
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3379191
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2925059
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.91
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.78
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
49000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3751440
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.68
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1125000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
2150000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1185500
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.26
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.61
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.75
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.55
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.48
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.77
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.67
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.87
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.47
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.61
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y124D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y313D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y339D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y259D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y273D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y277D
CY2018Q2 us-gaap Short Term Investments
ShortTermInvestments
825000
CY2017Q2 us-gaap Short Term Investments
ShortTermInvestments
3039000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
56260
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
82810
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6800
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
479000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
5030000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
10602000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
20782000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
16401000
CY2018 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
CY2017 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
CY2016 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
8000
CY2018 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
CY2017 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
27000
CY2016 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
154000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of consolidated financial statements in accordance with generally accepted accounting principles in the United States of America requires management of the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes of the Company including the allowance for doubtful accounts receivable; net realizable value of the enriched barium inventory; the estimated useful lives used in calculating depreciation and amortization on the Company&#x2019;s fixed assets, patents, trademarks and other assets; estimated amount and fair value of the asset retirement obligation related to the Company&#x2019;s production facilities; and inputs to the Black-Scholes calculation used in determining the expense related to share-based compensation including volatility, estimated lives and forfeiture rates of options granted. Accordingly, actual results could differ from those estimates and affect the amounts reported in the financial statements.</div></div></div></div></div>
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55159000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55016000
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55015000
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55017000
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55056000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55100000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55463000
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55011000
CY2016Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55017000
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55017000
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55017000

Files In Submission

Name View Source Status
0001437749-18-017492-index-headers.html Edgar Link pending
0001437749-18-017492-index.html Edgar Link pending
0001437749-18-017492.txt Edgar Link pending
0001437749-18-017492-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
ex_124298.htm Edgar Link pending
ex_124299.htm Edgar Link pending
ex_124300.htm Edgar Link pending
ex_124301.htm Edgar Link pending
ex_124302.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20180630.xml Edgar Link completed
isr-20180630.xsd Edgar Link pending
isr-20180630_cal.xml Edgar Link unprocessable
isr-20180630_def.xml Edgar Link unprocessable
isr-20180630_lab.xml Edgar Link unprocessable
isr-20180630_pre.xml Edgar Link unprocessable
isr20180630_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending